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Abstract
Introduction Pneumonia is a very common nosocomial infection
in intensive care units (ICUs). Many studies have investigated
risk factors for the development of infection and its
consequences. However, the evaluation in most of theses
studies disregards the fact that there are additional competing
events, such as discharge or death.
Methods A prospective cohort study was conducted over 18
months in five intensive care units at one university hospital. All
patients that were admitted for at least 2 days were included,
and surveillance of nosocomial pneumonia was conducted.
Various potential risk factors (baseline- and time-dependent)
were evaluated in two competing risks models: the acquisition
of nosocomial pneumonia and discharge (dead or alive; model
1) and for the risk of death in the ICU and discharge alive (model
2).
Results Patients from 1,876 admissions were included. A total
of 158 patients developed nosocomial pneumonia. The main
risk factors for nosocomial pneumonia in the multivariate
analysis in model 1 were: elective surgery (cause-specific
hazard ratio = 1.95; 95% CI 1.33 to 2.85) or emergency surgery
(1.59; 95% CI 1.10 to 2.28) prior to ICU admission, usage of a
nasogastric tube (3.04; 95% CI 1.25 to 7.37) and mechanical
ventilation (5.90; 95% CI 2.47 to 14.09). Nosocomial
pneumonia prolonged the length of ICU stay but was not directly
associated with a fatal outcome (p = 0.55).
Conclusion More studies using competing risk models, which
provide more accurate data compared to naive survival curves or
logistic models, should be carried out to verify the impact of risk
factors and patient characteristics for the acquisition of
nosocomial infections and infection-associated mortality.
Introduction
Nosocomial pneumonia (NP) is the most commonly reported
infection in intensive care units (ICUs), especially in mechani-
cally ventilated patients with an incidence of about 15 infec-
tions per 1,000 ventilation days [1]. This infection is
associated with a significantly increased length of hospital
stay and may have a considerable impact on morbidity and
mortality [2].
Endpoints, possible risk factors for the acquisition of NP and
the clinical outcome after the infection has occurred have
been addressed in numerous studies. However, many of these
studies did not take into account the fact that there are other
possible endpoints competing with the event of interest [3,4].
For example 'death' or 'discharge' are competing events for
the onset of infection. A competing risks methodology allows
for a better understanding of why NP increases mortality.
Unlike logistic regression, it allows modelling of the time-
dependency of certain procedures (for example intubation),
thereby avoiding biased results. For this, multi-state models
are a more accurate approach in order to consider competing
events [5,6]. We present here the results of a competing risks
analysis to address two major objectives: (1) to identify poten-
tial risk factors for NP in ICUs, considering discharge (dead or
CDC = Centers for Disease Control and Prevention; CSHR = cause-specific hazard ratio; ICU = intensive care unit; KISS = German Nosocomial 
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alive without prior NP) as the competing event, and (2) to
investigate several risk factors, including blood stream
infection, NP and other lower respiratory tract infections as
time-dependent risks, for mortality in ICU patients with dis-
charge (alive) as the competing endpoint.
Materials and methods
Patients and infections
The presenr study was conducted in five ICUs (one medical,
one surgical, one neurosurgical and two interdisciplinary) at
one German university hospital from February 2000 to July
2001 (a total study period of 18 months). All patients with a
duration of ICU stay of at least 2 days were enrolled. Prospec-
tive surveillance of nosocomial infections was performed by
trained staff of the German Nosocomial Infection Surveillance
System (KISS) [7] using the standardized US Centers for Dis-
ease Control and Prevention (CDC) definitions for NP [8]. The
method of surveillance remained unchanged over the study
period. As all investigations represented routine diagnostic
procedures, the Institutional Board on the Ethics of Clinical
Studies waived the need for informed consent. Further details
on the setting of the study are described elsewhere [9,10].
Analysis of risk factors for the acquisition of NP (model 
1)
In model 1, we studied risk factors for NP acquisition as well
as the competing risk 'discharge (dead or alive without prior
NP)' (Figure 1). After admission to the ICU (event 0) the
patient may (event 1) or may not (event 2) acquire NP. The
impact of the following baseline risk factors were investigated:
age, gender, simplified acute physiology score (SAPS) II, intu-
bation at ICU admission, infection present already at the time
point of ICU admission (pneumonia, urinary tract infection and
other infections), hospitalization prior to ICU admission, elec-
tive or emergency surgery before ICU admission (for example,
head trauma, multiple trauma, vascular surgery and neurosur-
gery), underlying diseases (cardial/pulmonal, gastrointestinal,
neurological, and metabolic/renal) and other underlying dis-
eases (including sepsis, malignancies or alcoholism). The
impact of the following time-dependent risk factors were inves-
tigated as time-dependent covariates (which start with value =
0 and may increase to 1): ventilation, chest drainage, colos-
tomy, enterostomy, jejunostomy, nasogastric tube and urinary
catheter. Age and SAPS II score were included in the model
as continuous variables; all other factors were binary variables
only.
Analysis of risk factors for mortality (model 2)
In model 2 we studied competing risks for mortality and dis-
charge (Figure 1). After admission to the ICU (event 0) the
patient may either die during their ICU stay (event 1) or be dis-
charged from the ICU (event 2). Here, we are mainly interested
in NP as a time-dependent risk factor for death in the ICU. The
same baseline and time-dependent risk factors as described
for model 1 were also applied in model 2. We also checked for
lower respiratory tract (LRT) infections other than pneumonia
on admission as baseline, and for nosocomial LRT and noso-
comial blood stream infection as time-dependent variables.
For both models 1 and 2 a competing risk analysis was per-
formed using cause-specific hazards [11,12]. This analysis fol-
lows separate Cox models for each event assuming
proportional hazards. In such competing risks analyses with
two endpoints, it is possible to interpret both cause-specific
hazard ratios (CSHRs) simultaneously for each risk factor.
Cumulative incidence functions have been displayed for each
endpoint. The proportional hazard assumptions were
assessed by study of the graphs of the Schoenfeld's residuals;
this technique is especially suitable for time-dependent covari-
ates [13]. The correlation matrices of each Cox model were
considered in order to check whether there are correlations
among the risk factors, respectively. Risk factors with a p value
≤ 0.157 for at least one of the CSHRs from the univariate anal-
ysis were included in a consecutive multivariate analysis. This
benchmark corresponds to the well established Akaike infor-
mation criterion for model selection [14]. A p value ≤ 0.05 was
considered statistically significant. For all analyses the R 2.4.1
software was used (R Foundation, Vienna, Austria), especially
the R functions coxph, cuminc and cox.zph, from the survival
and cmprsk libraries.
Figure 1
Competing endpoints in model 1 and model 2 Competing endpoints in model 1 and model 2.Available online http://ccforum.com/content/12/2/R44
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Additional data file 1 contains information on the required data
format and SAS and R calculations for cause-specific hazard
ratios in a competing risks analysis with time-dependent cov-
ariates represented.
Results
Patients and infections
A total of 7,269 patients were admitted to the ICUs (35,817
patient days) during the study period; of those, 1,876 admis-
sions (28,498 patient days) required treatment of ≥ 48 h. Only
those patients were included in this study. In all, 158 (8.4%) of
the included patients developed NP; 132 of these (83.5% of
all NP) were ventilator-associated NP (incidence of 8.5 per
1,000 ventilator days) and 33 of these (20.9% of all NP cases)
died in the ICU. Overall, in 214 of the 1,876 admissions
(11.4%) the patient died in the ICU. More details of risk factors
and outcomes are shown in Table 1.
Analysis of risk factors for the acquisition of nosocomial 
pneumonia (model 1)
Detailed information on the CSHRs of baseline and time-
dependent risk factors of model 1 are shown in Table 2.
According to this model, significant risk factors for the acqui-
sition of NP in our patient population were (1) pneumonia at
admission (CSHR = 0.02), whereas this risk factor also had a
reducing effect on the competing event discharge (CSHR =
0.66), (2) undergoing elective surgery prior to ICU admission
(CSHR = 1.95), and this effect was accentuated since the
CSHR was reduced for discharge (CSHR = 0.54), (3) under-
going emergency surgery prior to ICU admission (CSHR =
1.59), with no significant effect on discharge (CSHR = 1.08),
(4) use of a nasogastric tube (CSHR = 3.04), without effect
on discharge (CSHR = 0.89), and (5) mechanical ventilation
of the patient (CSHR = 5.90), which also significantly reduced
the CSHR for discharge from the ICU (CSHR = 0.53; 95% CI
0.45 to 0.62).
In addition to the analysis of model 1, we considered a model
with three competing events: nosocomial pneumonia, dis-
charge (alive) and death in the ICU. The CSHRs for pneumo-
nia are the same as in model 1 with the combined competing
event. However, the following risk factors had an opposite
influence on discharge (alive) and death in the ICU: SAPS II,
other infections on admission, surgical patients, metabolic/
renal underlying disease and other underlying diseases. This is
in line with the results for model 2.
Cumulative incidence functions (CIF)(model 1)
In addition to CSHR, cumulative incidence functions are suit-
able to illustrate the results of a competing risk analysis. This
was exemplarily performed for the risk factors of elective sur-
gery and pneumonia on admission. The CIF of pneumonia
starts to increase at an earlier time point for patients with elec-
tive surgery, but later for the competing endpoint death/dis-
charge (Figure 2a).
There is only a very low cause-specific risk to acquire nosoco-
mial pneumonia if the patient already had pneumonia on
admission (Figure 2b). Regarding discharge (dead or alive) as
the endpoint, the cumulative incidence function of the patient
group with pneumonia on admission is below the function of
the group without until about 40 days in the ICU, but above
afterwards.
Analysis of risk factors for mortality (model 2)
Detailed information on the CSHRs of baseline and time-
dependent risk factors of model 2 are shown in Table 3. The
baseline variables of age, SAPS II and other underlying dis-
eases significantly increased the CSHR for a fatal outcome.
No nosocomial infection was significantly associated with the
CSHR for death. However, patients with nosocomial pneumo-
nia stay significantly longer in the ICU (CSHR = 0.59); a simi-
lar effect was seen for patients with nosocomial LRT (CSHR
= 0.56). The CSHRs with regard to death in the ICU were not
significant for these nosocomial infections.
Cumulative incidence functions (model 2)
Although patients with an elective surgery had a lower cause-
specific risk of death (CSHR = 0.43), they tended to stay
longer in the ICU compared to those patients without an elec-
tive surgery (CSHR = 0.56). This effect can also be seen in
Figure 3a: the cumulative incidences of both endpoints start at
a later time point for patients with elective surgery.
Patients with pneumonia on admission stay longer in the ICU
(CSHR = 0.61); the CSHR for death was not significant. How-
ever, that also means that patients with pneumonia on admis-
sion die more frequently. This effect can be viewed in Figure
3b: the cause-specific risk of death decreased for patients
with pneumonia on admission at the beginning of their ICU
stay, but increased if they stay longer; the curves intersect.
Correlations among risk factors
The following time-dependent risk factors were highly corre-
lated among each other: colostomy, enterostomy and jejunos-
tomy (absolute values range between 0.6 to 0.9). There was a
low correlation of the baseline risk factor 'intubated on admis-
sion' and the SAPS II score (0.5). All other correlation coeffi-
cients ranged between -0.4 and 0.4.
Discussion
Many patient characteristics and significant risk factors for
ventilator-associated pneumonia have been published. These
include age, male gender, hospitalization prior to ICU
admission, length of ICU stay, treatment in large hospitals, a
low Glasgow Coma Scale (GCS), a poor Acute Physiology
and Chronic Health Evaluation (APACHE) II or SAPS II score,
respiratory failure, congestive heart failure, acute renal failure
and dialysis, bronchoscopy, tracheotomy, re-intubation, dura-
tion of mechanical ventilation, detection of certain multi drug
resistant pathogens, use of central vein catheters, bacterae-Critical Care    Vol 12 No 2    Wolkewitz et al.
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mia, enteral feeding, and application of sucralfat or corticoster-
oids, [4,15-24].
However, in most of these studies the time-dependent issue of
nosocomial infections was ignored, that is, the time-depend-
ent exposure was analysed as being known at time origin. This
results in time-dependent bias [25]. In addition, competing
events such as discharge or death were not explicitly mod-
elled. Recently, Resche-Rigon and co-authors point out that
ICU discharge should be considered a competing event, when
Table 1
Descriptive results of all risk factors and outcomes for all 1,876 admissions
Variables
Continuous: Mean SD
Age 60.0 18.4
SAPS II 35.2 18.7
Binary: Number Percentaqe
Female gender 764 40.72
Intubation on admission 848 45.20
Pneumonia on admission 220 11.73
LRT on admission 24 1.28
Urinary tract infection on admission 42 2.24
Other infections on admission 139 7.41
Hospitalization before admission 1,334 71.11
Surgical patients 433 23.08
Elective surgery before admission 883 47.07
Emergency surgery before admission 456 24.31
Cardial/pulmonary underlying disease 653 34.81
Neurological underlying disease 370 19.72
Metabolic/renal underlying disease 180 9.59
Other underlying disease 180 9.59
Time-dependent events (binary) Number of events Time (days) to event among those with event (Q25, median, Q75)
Discharge from ICU (alive) 1,632 (5,8,17)
Death in the ICU 214 (7,13,27)
Nosocomial pneumonia 158 (5,8,14)
Nosocomial blood stream infection 35 (7,13,26)
Nosocomial LRT 33 (5,6,10)
Ventilation 1,041 (1,1,1)
Chest drainage 366 (1,1,1)
Colostomy 44 (1,1,1)
Enterostomy 59 (1,1,1)
Jejunostomy 23 (1,1,10)
Nasogastric tube 1,263 (1,1,1)
Urinary catheter 1,608 (1,1,1)
ICU, intensive care unit; LRT, lower respiratory tract infection (other than pneumonia); Q, quartile; SAPS, simplified acute physiology score.Available online http://ccforum.com/content/12/2/R44
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estimating the mortality of ICU patients [26]. In this context,
Schoenfeld argued that one should better focus on whether
patients die rather then when they die, and therefore mortality
should be analysed as a binary variable (30-day mortality)
using a logistic regression [27]. But that means that the time-
dependent nature of nosocomial infections is ignored and it is
impossible to consider time-dependent risk factors as for
example, ventilation. In the present paper we applied multi-
state models in order to accurately take these two important
issues (that is, time-dependent risk-factors and competing
events) into account.
The competing risks situation at hand, however, requires care-
ful interpretation of the results: for example, in model 2 we find
that pneumonia on admission has a (non-significant reducing)
effect on the cause-specific hazard ratio of death, and an even
more reducing (and significant) effect on the CSHR of
discharge. This suggests that pneumonia on admission pro-
longs ICU stay; however, as the death hazard is not reduced
as much as the discharge hazard is, there will eventually be
more patients who are deceased [24]. Thus, the competing
risks model explains how pneumonia on admission contributes
to mortality: pneumonia on admission prolongs ICU stay; each
day, such a patient is again exposed to the (not significantly
altered) risk of dying. As a consequence, there will be more
Table 2
Multivariate analysis of cause-specific hazard ratios for the acquisition of nosocomial pneumonia (model 1)
Possible endpoints (competing risks)
Risk factor
Nosocomial pneumonia Discharge (dead or alive)
CSHR 95% CI p Value CSHR 95% CI p Value
Baseline:
Age (continuous variable) 1.01 1.00 to 1.02 0.18 1.00 1.00 to 1.01 0.01
Female gender 0.75 0.53 to 1.07 0.12 1.10 0.99 to 1.22 0.07
SAPS II (continuous variable) 1.00 0.98 to 1.01 0.42 0.98 0.98 to 0.99 < 0.01
Intubation on admission 0.89 0.71 to 1.13 0.35 1.05 0.96 to 1.14 0.32
Pneumonia on admission 0.02 0.00 to 0.12 < 0.01 0.66 0.56 to 0.77 < 0.01
Urinary tract infection on admission 1.86 0.60 to 5.82 0.28 0.81 0.56 to 1.18 0.28
Other infections on admission 1.08 0.59 to 1.98 0.79 0.72 0.59 to 0.89 < 0.01
Hospitalization before admission 0.73 0.50 to 1.05 0.09 0.91 0.81 to 1.02 0.10
Surgical patients 0.69 0.41 to 1.18 0.18 0.98 0.83 to 1.16 0.80
Elective surgery before admission 1.95 1.33 to 2.85 < 0.01 0.54 0.48 to 0.60 < 0.01
Emergency surgery before admission 1.59 1.10 to 2.28 0.01 1.08 0.95 to 1.23 0.25
Cardial/pulmonary underlying disease 1.32 0.86 to 2.04 0.20 0.84 0.73 to 0.97 0.02
Neurological underlying disease 1.25 0.78 to 2.00 0.36 0.94 0.81 to 1.09 0.41
Metabolic/renal underlying disease 0.76 0.35 to 1.65 0.48 0.80 0.65 to 0.99 0.04
Other underlying disease 1.49 0.83 to 2.66 0.18 1.00 0.81 to 1.24 1.00
Time-dependent:
Ventilation 5.90 2.47 to 14.09 < 0.01 0.53 0.45 to 0.62 < 0.01
Chest drainage 1.00 0.68 to 1.46 0.99 0.75 0.65 to 0.86 < 0.01
Colostomy 4.29 0.36 to 50.64 0.25 0.69 0.28 to 1.72 0.42
Enterostomy 0.14 0.01 to 2.10 0.15 1.64 0.61 to 4.45 0.33
Jejunostomy 2.47 0.45 to 13.58 0.30 0.41 0.16 to 1.04 0.06
Nasogastric tube 3.04 1.25 to 7.37 0.01 0.89 0.76 to 1.03 0.12
Urinary catheter 1.53 0.49 to 4.81 0.46 0.76 0.65 to 0.90 < 0.01
CSHR, cause-specific hazard ratio; SAPS, simplified acute physiology score.Critical Care    Vol 12 No 2    Wolkewitz et al.
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patients with pneumonia on admission, who stay longer and
die in the ICU.
In this study, we could show that elective surgery increases
the CSHR for nosocomial pneumonia (model 1). Although
nosocomial pneumonia is a risk factor for death, patients with
elective surgery have a lower cause-specific risk of dying
(model 2). However, these patients stay longer in the ICU.
There are two possible explanations for this: firstly, there is an
effect independent of whether they acquire NP during their
ICU stay, and secondly via a nosocomial pneumonia which
extends their ICU stay as well.
Our data from a competing risk model 1 confirmed mechanical
ventilation as the key risk factor for the development of NP,
with an increase in the CSHR of 5.90 (Table 2); this effect is
accentuated by the parallel competing risks analysis of CSHR
for direct discharge, which is significantly reduced by mechan-
ical ventilation. Additional significant factors in our study were
some form of surgery prior to ICU stay and the use of a
nasogastric tube, though as a limitation it should be remem-
bered that we did not consider all of the above-mentioned fac-
tors from previous works. Patients with diagnosed pneumonia
on admission were much less likely to develop NP (CSHR =
0.02; Table 2). Our interpretation of this is that very few
patients resolve from the initial pneumonia, thus they cannot
acquire an additional NP afterwards.
There is little doubt that the acquisition of NP increases the
length of ICU stay and the overall health care costs [18,28].
However it is controversial whether NP also influences ICU
mortality. Some studies found an increase in mortality due to
NP, while other did not or found an increase for certain patho-
gens only [24]. When comparing and evaluating these find-
ings the possibility of publication bias should be kept in mind.
It is less likely that studies without a significant increase in mor-
tality will get published. None of the studies carried out previ-
ously have ever used a model of time-dependent variables to
address the question of the mortality attributable to NP. Our
competing risk model 2 did not show an increase of the CSHR
for a fatal outcome after NP (CSHR = 0.87; p = 0.55; Table
3). However, as stated above, patients with NP require longer
treatment in the ICU on average. This was confirmed by our
findings (CSHR for discharge = 0.59; p < 0.01; Table 3). As
a consequence patients with NP are exposed to the (not sig-
nificantly altered) risk of dying in the ICU for a longer time
Figure 2
Cumulative incidence function for nosocomial pneumonia and discharge (dead or alive) (model 1) Cumulative incidence function for nosocomial pneumonia and discharge (dead or alive) (model 1). (a) In the two upper figures the risk factor 'elec-
tive surgery' is considered. (b) In the two lower figures the risk factor 'pneumonia on admission' is considered.Available online http://ccforum.com/content/12/2/R44
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period compared to patients without NP. As a result of this,
more patients will die after NP. This is a typical competing risks
phenomenon, which is discussed in detail by Beyersmann et
al. [29].
Conclusion
More studies using competing risk models should be carried
out to re-evaluate the impact of risk factors (especially time-
dependent variables) on the occurrence of nosocomial infec-
tions and patient outcomes thereafter.
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